Atsushi Usami

取締役 パートナー (Director, Partner) at UTEC - The University of Tokyo Edge Capital Partners · Joined 2013

Biography

Atsushi Usami is a Director and Partner of UTEC, responsible for seed and early stage investment centred on life sciences. UTEC's own profile states verbatim that he currently holds concurrent outside director positions at portfolio companies bitBiome, Bugworks Research, SOLA Biosciences, RegCell, EditForce, Celaid Therapeutics and United Immunity (現在、投資先の...等の社外取締役を兼任). It states he previously handled the investments in OriCiro Genomics, Inc. (acquired by Moderna, Inc.) and Repertoire Genesis Inc. (acquired by Eurofins Scientific SE). He acts as a supporter of the Life Science Innovation Network Japan (LINK-J). Before UTEC he worked at Mitsubishi Research Institute on new business strategy planning and management planning support for life sciences and other manufacturing companies, and he joined UTEC in October 2013. He holds a doctorate from the University of Tokyo Graduate School of Pharmaceutical Sciences and is a licensed pharmacist. In 2023 he received the Venture Capitalist Encouragement Award at the 23rd Japan Venture Awards.

Education

• The University of Tokyo, Graduate School of Pharmaceutical Sciences, PhD (medicinal life science)
• Licensed pharmacist (薬剤師)

Previous Experience

• Mitsubishi Research Institute, Inc. (株式会社三菱総合研究所) - new business strategy and management planning support for life sciences and other manufacturing sectors
• UTEC - joined October 2013

Notable Investments

Board Seats

• 社外取締役 (Outside Director), bitBiome株式会社
• 社外取締役 (Outside Director), Bugworks Research, Inc.
• 社外取締役 (Outside Director), SOLA Biosciences, Inc.
• 社外取締役 (Outside Director), RegCell, Inc.
• 社外取締役 (Outside Director), エディットフォース株式会社 (EditForce, Inc.)
• 社外取締役 (Outside Director), セレイドセラピューティクス株式会社 (Celaid Therapeutics, Inc.)
• 社外取締役 (Outside Director), ユナイテッド・イミュニティ株式会社 (United Immunity, Co., Ltd.)

Career Timeline

Sources & References